Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.82
+0.05 (0.74%)
Apr 8, 2026, 12:44 PM EDT - Market open
Eupraxia Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$15.00
Upside
+119.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +61.29% | Mar 17, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $19 | Buy | Maintains | $11 → $19 | +178.59% | Jan 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +75.95% | Jan 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +75.95% | Aug 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +61.29% | Jul 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +75.95% | Jun 26, 2025 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +31.96% | Nov 14, 2024 |